Edwards Lifesciences Corp

NYSE:EW   12:29:33 PM EDT
98.83
-1.70 (-1.69%)
Other Pre-Announcement

Edwards Lifesciences Corp - Expect Strong Double-Digit Adjusted Eps Growth In Second Half Of The Year

Published: 07/28/2022 20:32 GMT
Edwards Lifesciences Corp (EW) - Edwards Lifesciences Corp - Expects About 10% Underlying Sales Growth in Second Half of Year.
Edwards Lifesciences Corp - Expect Strong Double-digit Adjusted EPS Growth in Second Half of the Year.
Edwards Lifesciences Corp - for Total Edwards, Now Expects Full Year 2022 Sales of $5.35 Billion to $5.55 Billion.
Edwards Lifesciences Corp - Now Expects Full Year Adjusted EPS Guidance at Bottom End of Original Guidance Range of $2.50 to $2.65.
Edwards Lifesciences Corp - for Q3, Projects Total Sales to Be Between $1.30 Billion and $1.37 Billion, and Adjusted EPS of $0.58 to $0.66.